Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 5
2006 1
2007 2
2008 5
2009 10
2010 13
2011 15
2012 14
2013 14
2014 11
2015 25
2016 27
2017 21
2018 15
2019 18
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Results by year
Filters applied: . Clear all
Page 1
The clinical approach towards chondrosarcoma
Gelderblom H, et al. Oncologist 2008 - Review. Among authors: Bovee JV. PMID 18378543 Free article.
Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma
Verschoor AJ, et al. Oncologist 2019. Among authors: Bovee JVMG. PMID 31857445 Free article.
Until 1997 a 5 g/m(2) regimen was used, and from 1997 onwards a 9 g/m(2) regimen was used. Overall survival (OS) from start of ifosfamide was the primary endpoint. ...RESULTS: Sixty-two patients were selected with recurrent/metastatic osteosarcoma treated with second-line ifosfamide monotherapy (dose of 5 g/m(2), n = 26; 9 g/m(2), n = 36). ...
Until 1997 a 5 g/m(2) regimen was used, and from 1997 onwards a 9 g/m(2) regimen was used. Overall survival (OS) …
173 results
Jump to page
Feedback